{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:35:48Z","timestamp":1753922148582,"version":"3.37.3"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007650","name":"FUNCIS","doi-asserted-by":"crossref","award":["PI: 08\/115"],"award-info":[{"award-number":["PI: 08\/115"]}],"id":[{"id":"10.13039\/100007650","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0189348","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T14:04:12Z","timestamp":1512741852000},"page":"e0189348","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["A three-month longitudinal study of changes in day\/night serum total antioxidant capacity in paranoid schizophrenia"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7663-1154","authenticated-orcid":true,"given":"Armando L.","family":"Morera-Fumero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estefan\u00eda","family":"D\u00edaz-Mesa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Abreu-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lourdes","family":"Fernandez-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Guillen-Pino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"year":"2013","key":"ref1","article-title":"Diagnostic and Statistical Manual of Mental Disorders"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00406-012-0294-y","article-title":"Neurobiology of schizophrenia: from outcome to pathophysiological insights","volume":"262","author":"P Falkai","year":"2012","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"ref3","unstructured":"International Union of Pure and Applied Chemistry (IUPAC). Radicals (free radicals). Compendium of chemical terminology. Gold book. 2 ed. Oxford: 1997. p. 1234."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","article-title":"Free radicals, antioxidant defense systems, and schizophrenia","volume":"46","author":"JQ Wu","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","article-title":"Meta-analysis of oxidative stress in schizophrenia","volume":"74","author":"J Flatow","year":"2013","journal-title":"Biol Psychiatry"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/hup.1102","article-title":"Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study","volume":"25","author":"Y Nakano","year":"2010","journal-title":"Hum Psychopharmacol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jpsychires.2010.03.008","article-title":"Reduced status of plasma total antioxidant capacity in schizophrenia with tardive dyskinesia","volume":"44","author":"dC Chen","year":"2010","journal-title":"J Psychiatr Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pnpbp.2012.05.005","article-title":"The reduction of superoxide dismutase activity is associated with the severity of neurological soft signs in patients with schizophrenia","volume":"39","author":"M Raffa","year":"2012","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.schres.2012.04.009","article-title":"Plasma total antioxidant status and cognitive impairments in schizophrenia","volume":"139","author":"XY Zhang","year":"2012","journal-title":"Schizophr Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-244X-11-124","article-title":"Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients","volume":"11","author":"M Raffa","year":"2011","journal-title":"BMC Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","article-title":"A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation","volume":"37","author":"O Erel","year":"2004","journal-title":"Clin Biochem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/24750573.2017.1293243","article-title":"Oxidative metabolism may be associated with negative symptoms in schizophrenia","volume":"27","author":"M Gunes","year":"2017","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.psychres.2017.01.043","article-title":"Low levels of serum total antioxidant capacity and presence at admission and absence at discharge of a day\/night change as a marker of acute paranoid schizophrenia relapse","volume":"249","author":"AL Morera-Fumero","year":"2017","journal-title":"Psychiatry Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(98)00030-9","article-title":"Reduced status of plasma total antioxidant capacity in schizophrenia","volume":"32","author":"JK Yao","year":"1998","journal-title":"Schizophr Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1440-1819.2009.02015.x","article-title":"Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile","volume":"63","author":"O Pazvantoglu","year":"2009","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-079X.2007.00467.x","article-title":"Daytime\/night-time and summer\/winter melatonin and malondialdehyde rhythms: an inverse relationship","volume":"43","author":"AL Morera","year":"2007","journal-title":"J Pineal Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/15622970801901802","article-title":"Winter\/summer seasonal changes in malondialdehyde formation as a source of variance in oxidative stress schizophrenia research","volume":"10","author":"AL Morera","year":"2009","journal-title":"World J Biol Psychiatry"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-079X.1999.tb00597.x","article-title":"Physiological levels of melatonin contribute to the antioxidant capacity of human serum","volume":"27","author":"S Benot","year":"1999","journal-title":"J Pineal Res"},{"key":"ref19","first-page":"1","article-title":"Cejas-Mendez MDR3, Guillen-Pino F. Day\/night and summer\/winter changes in serum total antioxidant capacity","volume":"14","author":"AL Morera-Fumero","year":"2018","journal-title":"Med Chem"},{"article-title":"ECDEU Assessment Manual for Psychopharmacology","year":"1976","author":"W Guy","key":"ref20"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"SW Woods","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1042\/cs0840407","article-title":"A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates","volume":"84","author":"NJ Miller","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1440-1819.2010.02132.x","article-title":"Lipid peroxidation in patients with schizophrenia","volume":"64","author":"A Dietrich-Muszalska","year":"2010","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1440-1819.2006.01532.x","article-title":"Total antioxidant response in patients with schizophrenia","volume":"60","author":"B M Ustundag","year":"2006","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000239684","article-title":"A defect in the antioxidant defense system in schizophrenia","volume":"60","author":"O Virit","year":"2009","journal-title":"Neuropsychobiology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000202823","article-title":"Potential effect of olanzapine on total antioxidant status and lipid peroxidation in schizophrenic patients","volume":"59","author":"BM Al-Chalabi","year":"2009","journal-title":"Neuropsychobiology"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.pnpbp.2007.03.008","article-title":"Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment","volume":"31","author":"A Sarandol","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.3390\/ijms14059037","article-title":"Role of melatonin in schizophrenia","volume":"14","author":"AL Morera-Fumero","year":"2013","journal-title":"Int J Mol Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0189348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T01:07:46Z","timestamp":1540343266000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0189348"}},"subtitle":[],"editor":[{"given":"Weihua","family":"YUE","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0189348","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,12,8]]}}}